n(g),n(g')-dimethyl-l-arginine has been researched along with Peripheral Vascular Diseases in 8 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 9.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 7.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| "We investigated in this double-blind, controlled study whether prolonged intermittent infusion therapy with L-arginine improves the clinical symptoms of patients with intermittent claudication, as compared with the endothelium-independent vasodilator prostaglandin E1, and control patients." | 5.08 | Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. ( Alexander, K; Bode-Böger, SM; Böger, RH; Creutzig, A; Frölich, JC; Thiele, W, 1998) |
| "Hyperhomocysteinemia is associated with an enhanced risk for cardiovascular disease." | 3.72 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Hornig, B; Münzel, T; Sydow, K; Tsikas, D, 2004) |
| " Mechanisms responsible for endothelial dysfunction in hyperhomocyst(e)inemia may involve impaired bioavailability of NO, possibly secondary to accumulation of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) and increased oxidative stress." | 2.71 | ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. ( Arakawa, N; Bode-Böger, SM; Böger, RH; Frölich, JC; Hornig, B; Schwedhelm, E; Sydow, K; Tsikas, D, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sydow, K | 2 |
| Schwedhelm, E | 1 |
| Arakawa, N | 2 |
| Bode-Böger, SM | 4 |
| Tsikas, D | 2 |
| Hornig, B | 2 |
| Frölich, JC | 3 |
| Böger, RH | 4 |
| Stühlinger, MC | 1 |
| Oka, RK | 1 |
| Graf, EE | 1 |
| Schmölzer, I | 1 |
| Upson, BM | 1 |
| Kapoor, O | 1 |
| Szuba, A | 1 |
| Malinow, MR | 1 |
| Wascher, TC | 1 |
| Pachinger, O | 1 |
| Cooke, JP | 1 |
| Tsuda, K | 1 |
| Nishio, I | 1 |
| Münzel, T | 1 |
| Mittermayer, F | 1 |
| Krzyzanowska, K | 1 |
| Exner, M | 1 |
| Mlekusch, W | 1 |
| Amighi, J | 1 |
| Sabeti, S | 1 |
| Minar, E | 1 |
| Müller, M | 1 |
| Wolzt, M | 1 |
| Schillinger, M | 1 |
| Blardi, P | 1 |
| de Lalla, A | 1 |
| Pieragalli, D | 1 |
| De Franco, V | 1 |
| Meini, S | 1 |
| Ceccatelli, L | 1 |
| Auteri, A | 1 |
| Thiele, W | 2 |
| Junker, W | 1 |
| Alexander, K | 2 |
| Creutzig, A | 1 |
4 trials available for n(g),n(g')-dimethyl-l-arginine and Peripheral Vascular Diseases
| Article | Year |
|---|---|
ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Topics: Aged; Analysis of Variance; Arginine; Arterial Occlusive Diseases; Double-Blind Method; Female; Foli | 2003 |
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Topics: Adult; Age Factors; Aged; Arginine; Arteriosclerosis; Brachial Artery; Endothelium, Vascular; Female | 2003 |
Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Blood Platelets; Blood Pressure; Dia | 2006 |
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Topics: Aged; Aged, 80 and over; Alprostadil; Arginine; Arterial Occlusive Diseases; Blood Flow Velocity; Ch | 1998 |
4 other studies available for n(g),n(g')-dimethyl-l-arginine and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Asymmetric dimethylarginine and circulatory disorders in postmenopausal women.
Topics: Aged; Arginine; Endothelium, Vascular; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Pe | 2004 |
Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Arterial Occlusive Diseases; Chronic Disease; Endothelium, | 2004 |
Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
Topics: Aged; Arginine; Arteries; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Stud | 2006 |
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Arterial Occlusive Diseases; Cyclic GMP; Disease Pr | 1997 |